GlycoMantra received a SBIR Phase 1 grant from the NIDDK (NIH)
June 3, 2020
GlycoMantra received a SBIR Phase 1 grant from the NIDDK (NIH) June 03, 2020 GlycoMantra…
GlycoMantra will present at the Oncology Investor Conference.
March 25, 2020
GlycoMantra will present at the Oncology Investor Conference. GlycoMantra has been selected to pitch at the…
Glycomantra Will Present At RESI Europe
March 12, 2020
GlycoMantra has been selected to pitch in the Featured Company Pitch Session at RESI Europe meeting.
GlycoMantra received a SBIR Phase 1 grant from the NIDDK (NIH)
September 24, 2018
GlycoMantra was awarded a SBIR Phase 1 grant to investigate NASH fibrosis.